Swartz Robin — SEC Form 4 filings
SEC reporting owner CIK 1909636. 12 Form 4 filings on record with FilingPulse; latest filed 2026-02-26.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-19 to 2026-02-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 10 filings — 43,206 shares, $216,343 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 6,500 shares @ $5.65 ($36,725) in Voyager Therapeutics, Inc., filed 2024-12-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | COO & CBO | 12 | — | 10 legs · 43,206 sh · $216,343 | 6 |
Form 4 filings — Swartz Robin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-26 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 6,458 @ $3.77 | EDGAR |
| 2026-02-20 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,882 @ $3.44 | EDGAR |
| 2026-02-11 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 4,569 @ $3.85 | EDGAR |
| 2026-02-10 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,894 @ $4.25 · Grant/award (A): 71,250 @ $0 · Grant/award (A): 142,500 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 6,950 @ $4.45 | EDGAR |
| 2025-01-15 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,087 @ $5.09 | EDGAR |
| 2024-12-26 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 6,500 @ $5.65 | EDGAR |
| 2024-04-03 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 1,357 @ $9.88 | EDGAR |
| 2024-02-22 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 3,966 @ $7.45 | EDGAR |
| 2024-02-16 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 2,543 @ $7.15 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909636 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →